Credent targets over Rs 320 crore in FY27, Rs 1,000 crore by FY30

Credent is targeting revenue of over Rs 320 crore in FY27 and approximately Rs 1,000 crore by FY30, supported by H1 FY27 revenue of Rs 138 crore, up 53% year on year from Rs 90 crore. Management said the 45% to 50% annual growth plan excludes acquisitions and depends on organic expansion.

What are Credent’s FY27 and FY30 revenue targets?

Credent is targeting more than Rs 320 crore of revenue in FY27 and approximately Rs 1,000 crore by 2030, with management describing the longer-term figure as subject to a 10% to 15% range. The FY27 target follows H1 FY27 revenue of Rs 138 crore, compared with Rs 90 crore in H1 FY26.

The target requires a larger second-half contribution than the first half. Management said its business normally generates 40% to 45% of annual revenue in H1 and 55% to 60% in H2 because of industry seasonality. It cited prior-year revenue of Rs 216 crore in one response, while a transcript note identified the FY26 consolidated revenue reference as about Rs 214 crore.

Is Credent’s growth target entirely organic?

Yes. Credent management confirmed that its stated minimum 45% to 50% compound annual growth rate, or CAGR, through 2030 excludes inorganic growth. Acquisitions could add business beyond this plan, but management said the revenue targets presented on the call are based on the existing business and organic expansion.

Management identified existing-client expansion, new client wins and city additions as the main mechanisms. One enterprise client can generate approximately Rs 12 crore to Rs 18 crore of annual revenue, according to management, while a mid-sized client can generate Rs 4 crore to Rs 6 crore. Credent said it is targeting five to 10 new mid-sized clients while expanding work with current customers.

Credent was also evaluating acquisition opportunities in wellness or logistics, but said no transaction had been finalised. Management said it was looking at profitable businesses with revenue below Rs 100 crore and valuations at multiples of around 10 to 12. It added that any future equity raising would be considered for acquisitions rather than organic growth through 2030.

Which businesses are expected to drive Credent’s growth?

Healthcare services was Credent’s largest reported H1 FY27 revenue segment, accounting for 45.84%, followed by IT and operational supply chain at 29.35% and logistics services at 24.81%. Management said its revenue model is based on patient collections and logistics pickups, with charges levied per collection or per pickup.

Management expects healthcare and wellness services to contribute more to profitability improvement than logistics over the next two to three years. It said logistics faces greater competition, while healthcare services benefit from Credent’s national presence in its stated operating niche. This segment mix is relevant to management’s stated objective of lifting the earnings before interest, tax, depreciation and amortisation, or EBITDA, margin over three years.

Credent also plans to capitalise its On-Demand product during FY27. Management described the product as a prepaid platform through which smaller laboratories can book collections and logistics pickups using a wallet model. It named Wockhardt and Thyrocare as clients onboarded, while saying prices can vary by timing, turnaround time, frequency and monthly business value.

What profitability does Credent expect as it expands?

Credent reported H1 FY27 EBITDA of Rs 18 crore, up 53% year on year, while its EBITDA margin remained at 13%, the same as in H1 FY26. Management said it expects the margin to remain around 13% initially, with any improvement dependent on operating performance, working-capital improvement and operating-cycle efficiencies.

Management identified an EBITDA margin of 15% to 16% as an objective over the next three years. It also said that, at approximately Rs 1,000 crore of revenue in 2030, it was tentatively targeting a 10% profit after tax, or PAT, margin and PAT of more than Rs 100 crore. These figures are management targets rather than reported results.

H1 FY27 PAT was Rs 14.65 crore, up 95% year on year, and the PAT margin rose to 11% from 8% in H1 FY26. Reported PAT included a one-time tax credit of Rs 1.78 crore. Excluding that credit, management said PAT was Rs 12.87 crore, representing growth of 71%.

How will Credent fund the expansion plan?

Credent said it completed its initial public offering, or IPO, in August 2026 and had used approximately Rs 21.65 crore of proceeds by September 2026. The proceeds were earmarked for working capital, investment in wholly owned subsidiary Credent Healthcare Private Limited, machinery-related capital expenditure, debt repayment and general corporate purposes.

Management said it had used about Rs 4 crore to Rs 5 crore of the Rs 93.9 crore IPO proceeds for working capital by September 2026. At that date, Credent reported borrowings of around Rs 22 crore and cash and bank balances of Rs 74 crore. Its debt-to-equity ratio was 0.2 times in H1 FY27.

Credent’s management said it does not expect to need fresh market funding for organic growth through 2030. That view depends on deploying IPO proceeds and improving collections: debtor ageing was about 60 days, and management is targeting less than 45 days. New client agreements are being structured with payment terms of no more than 30 days, compared with earlier terms of 45 to 60 days.

Can Credent scale operations without heavy capital expenditure?

Credent described its model as low in capital expenditure because it seeks a minimum business guarantee from a client before entering a new city. Management said it may incur operating-team costs on a city launch but does not expect a large infrastructure investment or an expansion led by losses.

At the targeted Rs 320 crore revenue scale, management said Credent would operate with about 7,000 fleet personnel. It estimated that this could rise to 15,000 to 16,000 at Rs 1,000 crore of revenue if operating leverage improves, or to about 20,000 without such improvement. Management said current warehouses and offices are sufficient for collection and wellness operations, while the larger-warehouse logistics business is not being expanded in FY27.

Conclusion

Credent’s disclosed growth plan rests on an organic route from Rs 138 crore of H1 FY27 revenue to more than Rs 320 crore for FY27 and approximately Rs 1,000 crore by FY30. The plan combines enterprise and mid-sized client additions, deeper work with existing clients, healthcare and wellness services, and the prepaid On-Demand product rather than relying on acquisitions.

The next measures to watch are H2 FY27 delivery against the stated 55% to 60% seasonal revenue share, progress in reducing debtor ageing from 60 days to below 45 days, and movement toward the 15% to 16% EBITDA-margin objective over three years. Management also said cash flow may turn positive by next year’s H2 and that overseas expansion, initially focused on the UAE or Middle East, may begin next year or later.